Technical Analysis for CEMI - Chembio Diagnostics, Inc.

Grade Last Price % Change Price Change
grade B 6.7 4.36% 0.28
CEMI closed up 4.36 percent on Friday, September 13, 2019, on 1.16 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical CEMI trend table...

Date Alert Name Type % Chg
180 Bullish Setup Bullish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Narrow Range Bar Range Contraction 4.36%
NR7 Range Contraction 4.36%
Upper Bollinger Band Walk Strength 4.36%
Wide Bands Range Expansion 4.36%
Overbought Stochastic Strength 4.36%
Upper Bollinger Band Touch Strength 4.36%

Older signals for CEMI ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Chembio Diagnostics, Inc., together with its wholly-owned subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care diagnostic tests that detect infectious diseases. It offers rapid tests for the detection of HIV antibodies, syphilis, and canine leishmaniasis. Its products include lateral flow rapid HIV tests and Dual Path Platform (DPP) HIV Test, which detect antibodies to HIV 1 and 2 with visually interpreted results; a multiplex Syphilis Screen and Confirm test, a multiplex test for the separate detection of antibodies to HIV and Syphilis; and a rapid test for the detection of Hepatitis-C antibodies and antigens. The company sells its products under its STAT PAK, SURE CHECK, or DPP trademarks, as well as under the private labels of its marketing partners. Chembio Diagnostics, Inc. sells its products to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. The company has collaboration agreements with the Oswaldo Cruz Foundation relating to products based on its DPP technology products. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Medford, New York.
Medicine Medical Specialties Immunology Infectious Diseases Antibodies Immune System Antibody Medical Tests Diagnostic Tests HIV Technology Products HIV/Aids Ortho Clinical Diagnostics Retail Establishments Diagnosis Of Hiv/Aids
Is CEMI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 10.79
52 Week Low 4.39
Average Volume 39,769
200-Day Moving Average 6.3195
50-Day Moving Average 5.756
20-Day Moving Average 5.5575
10-Day Moving Average 6.016
Average True Range 0.4495
ADX 32.43
+DI 29.8357
-DI 9.2963
Chandelier Exit (Long, 3 ATRs ) 5.5515
Chandelier Exit (Short, 3 ATRs ) 5.7385
Upper Bollinger Band 6.7459
Lower Bollinger Band 4.3691
Percent B (%b) 0.98
BandWidth 42.767431
MACD Line 0.2227
MACD Signal Line 0.0449
MACD Histogram 0.1778
Fundamentals Value
Market Cap 82.47 Million
Num Shares 12.3 Million
EPS -0.71
Price-to-Earnings (P/E) Ratio -9.44
Price-to-Sales 4.04
Price-to-Book 4.83
PEG Ratio -0.47
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.10
Resistance 3 (R3) 7.06 6.88 7.03
Resistance 2 (R2) 6.88 6.78 6.90 7.01
Resistance 1 (R1) 6.79 6.71 6.83 6.83 6.99
Pivot Point 6.61 6.61 6.63 6.63 6.61
Support 1 (S1) 6.52 6.51 6.57 6.57 6.41
Support 2 (S2) 6.34 6.45 6.37 6.39
Support 3 (S3) 6.25 6.34 6.37
Support 4 (S4) 6.30